Physician profile
Anthony Eguakhide Nebor
NPI 1154685881
$14,706.97
in general payments reported to CMS, 2019-2025
27 companies · $4,055 in 2025
The $4,055 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $684 · 2022: $4,100 · 2023: $4,368 · 2024: $1,500 · 2025: $4,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,600 · Food and Beverage: $3,982 · Travel and Lodging: $1,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,599.99 |
| Food and Beverage | $3,982.07 |
| Travel and Lodging | $1,340.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,869.67 | 2023-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $2,376.74 | 2021-2025 | Fasenra, Breztri, Tezspire |
| Ethicon INC. | $1,814.53 | 2021-2022 | |
| Glaxosmithkline, LLC. | $1,352.49 | 2021-2025 | Nucala, Trelegy Ellipta |
| Medical Device Business Services, INC. | $1,149.97 | 2022 | |
| Amgen INC. | $768.19 | 2021-2025 | Tezspire |
| Viatris Specialty LLC | $164.18 | 2025 | Yupelri |
| Baxter Healthcare | $144.07 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Tactile Systems Technology INC | $108.16 | 2022-2024 | Flexitouch Plus, Entre Plus |
| Mallinckrodt Hospital Products INC. | $99.99 | 2023 | Acthar |
| Regeneron Healthcare Solutions, INC. | $97.83 | 2023 | Dupixent |
| Genzyme Corporation | $94.81 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.42 | 2021-2023 | Ofev |
| Mylan Specialty L.P. | $74.19 | 2022 | |
| Novartis Pharmaceuticals Corporation | $65.39 | 2024-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $61.28 | 2022-2024 | Watchpatone |
| Actelion Pharmaceuticals US, INC. | $48.28 | 2022-2024 | Uptravi, Opsumit |
| Electromed, INC. | $47.40 | 2021-2022 | |
| Inspire Medical Systems, INC. | $45.27 | 2024 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $44.43 | 2022-2023 | Glassia |
| Inogen, INC. | $40.85 | 2022 | |
| Philips North America LLC | $34.55 | 2021-2025 | Vest Therapy Und |
| Insmed, INC. | $34.08 | 2023-2025 | Arikayce |
| Phadia US INC. | $29.56 | 2022-2023 | Immunocap |
| Ars Pharmaceuticals Operations, INC. | $22.51 | 2025 | Neffy |
| Pfizer INC. | $12.61 | 2021 | |
| Pinnacle Biologics, INC | $12.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Nebor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.